Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study-Reference-Cited by-同舟云学术

Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study

Published:2021-05 Issue: Volume: Page:
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Sugiyama Seiko,Yamamoto Takenobu,Aoyama Yumi

Funder

Ministry of Health, Labour and Welfare

Kawasaki Medical School

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. The role of incretins in glucose homeostasis and diabetes treatment;Kim;Pharmacol Rev,2008

2. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions;Shao;Pharmacol Ther,2020

3. Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: a retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy;Siegel;J Am Acad Dermatol,2018

4. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy;Shelburne;Medicine (Baltimore),2002

5. Immune reconstitution syndrome associated with opportunistic mycoses;Singh;Lancet Infect Dis,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathological function of neutrophils in pemphigoid diseases;Dermatologica Sinica;2024-04

2. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid diagnosed by oral manifestation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-11

3. Biomarkers for predicting immune reconstitution inflammatory syndrome in dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid: A retrospective observational study with a case series;JEADV Clinical Practice;2023-09-11

4. Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome;JEADV Clinical Practice;2023-04-17

5. Adaptive and innate immune pathogenesis of bullous pemphigoid: A review;Frontiers in Immunology;2023-03-10